Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Multiple Sclerosis: An Update.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Rebif approval application
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
Neurotrophic and Neuroprotective effects of muscle contraction.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Rare onset symptoms in multiple sclerosis.
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
10 years of interferon beta-1b (Beta feron therapy.
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Pages
« first
‹ previous
…
34
35
36
37
38
39
40
41
42
…
next ›
last »